Lombardi Comprehensive Cancer Center at Georgetown University — Georgetown, Washington

Lombardi Comprehensive Cancer Center at Georgetown University is a clinical research site located in Georgetown, Washington, United States 20057.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Lombardi Comprehensive Cancer Center at Georgetown University has participated in 1 clinical trials.

Therapeutic areas: Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder.

Sponsors: Spur Therapeutics.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Comprehensive Cancer Center at Georgetown University?

Lombardi Comprehensive Cancer Center at Georgetown University has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Comprehensive Cancer Center at Georgetown University conducted?

Lombardi Comprehensive Cancer Center at Georgetown University has 1 clinical trials on record. Their work covers Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder.

Is Lombardi Comprehensive Cancer Center at Georgetown University accredited by Crixeo Health?

Lombardi Comprehensive Cancer Center at Georgetown University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lombardi Comprehensive Cancer Center at Georgetown University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.